Decentralized Clinical Trials for Enhanced Patient Engagement

Decentralized clinical trials- Innovating for a Digital World

Decentralized clinical trials (DCTs) have revolutionized clinical research, offering a flexible and patient-centric approach that leverages technology to conduct studies remotely. This shift from traditional site-based trials to decentralized models enables participants to engage in the trials from the comfort of their homes or other convenient locations. Decentralized clinical trials companies have emerged as leaders in this innovative field, providing robust solutions to streamline study processes. The adoption of DCTs, across the globe, is particularly noteworthy, with the best decentralized clinical trial vendors offering cutting-edge technology and support to ensure the success of these trials.

Our expertise in DCTs allows us to design and implement studies that enhance patient convenience and engagement while maintaining rigorous data quality and regulatory compliance. By utilizing telemedicine, wearable devices, and home health visits, we bring the trial to the patient, reducing barriers to participation and improving recruitment and retention rates. Our DCT solutions are tailored to the specific needs of each study, providing flexible and scalable options that enhance study accessibility and efficiency. We ensure that all decentralized activities are seamlessly integrated with traditional study components, providing a cohesive and comprehensive trial experience. Powering possibilities in decentralized clinical trials to accelerate trial timelines and reduce the overall cost of data collection.

Benefits of Decentralized Clinical Trials

Presentation

Alt Text

How does Clinical Data Management adapt to Decentralized Clinical Trials?

Dr. Yun Lu, PhD, VP & Chief Science and Innovation officer presented a session on the evolution of Clinical Research and Decentralized Clinical Trials, Clinical Data and Technologies, and more.

Brochure

Alt Text

Efficient Clinical Trials: Real-Time Oversight & Insights

Learn how we ensure adherence to study timelines and milestones through In-depth domain expertise, robust medical and scientific talent pool, adoption and use of proven technologies.

ARTICLE

Alt Text

Key Takeaways from The FDA Guidance on DCTs

Published in: Life Science Leader
Explore highlights of the FDA guidance for conducting DCTs in the recent article, including embracing Novel Technologies, adapting Informed Consent, Centralized Monitoring, and more.

Decentralized Clinical Trials (DCT)

DCT refers to a clinical trial where some or all of the trial-related activities occur at locations other than traditional clinical trial sites.

Image

Gain the Navitas Life Sciences Edge

Holistic Approach

Holistic Approach

Balancing scientific rigor with cost-effectiveness.
8 Offices World Wide

8 Offices World Wide

Including 4 delivery centers across the globe.

Specialized Focus

Specialized Focus

Expertise in vulnerable populations and niche areas.
Strategic Support

Strategic Support

From TPP to regulatory compliance, we cover all bases.
Expert Team

Expert Team

Medical monitors with rich academic and industry experience.

BLOGS

Alt Text

Decentralized Clinical Trial Support during COVID-19 Pandemic

DCTs leverage the use of emerging technology to ensure better patient participation. There are several advantages that are provided by DCTs when compared with traditional methods.
Alt Text

5 Solutions to Data Collection Challenges in Virtual Clinical Trials

Digital transformation is made possible by leveraging advancements in digital technology but, to sustain this transformative change, there is a need for enhanced support systems.
Alt Text

Our Experts Explore the Potential of Decentralized Clinical Trials and Our Unique Capabilities

We have the expertise to navigate the complexities of decentralized trials, ensuring we deliver results with the highest standards of quality and compliance.

Get in touch

Solutions

Advisory Services

Clinical Development

Post Marketing

Therapeutics

Core Therapeutics

Interdisciplinary Therapeutics

Niche Therapeutics

Sectors

Governance

About Us